Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
01/2008
01/16/2008EP1458684B1 Therapeutic heterocycles as bradykinin b2 receptor antagonists
01/16/2008CN101107226A Phenoxyacetic acid derivatives useful for treating respiratory diseases
01/16/2008CN101106977A Direct compression formulation and process
01/16/2008CN100361994C Tetraphenyl porphyrin derivative and its application in organic electroluminescent device
01/16/2008CN100361972C Synthesis of tenuazonic acid and iso-tenuazonic acid
01/16/2008CN100361971C Double functional group L-proline derivative with adjustable catalytic activity and its prepn
01/15/2008US7319166 Method of purifying a raw melt of at least one monomer by crystallization
01/15/2008US7319152 5-Aryl-indan-1-one and analogs useful as progesterone receptor modulators
01/15/2008US7319111 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists
01/15/2008US7319098 1,3-dioxoisoindole derivatives having selective antagonism of T-type calcium channel
01/15/2008US7319084 An addition polymerization catalyst of a cationic transition metal complex of a neutral bidentate ligand including a pyrole ring and an anion or nickelbis(1,5-cyclooctadiene), tri(pentafluorophenyl)borane and the neutral bidentate ligand; heat resistance; stability; steric hinderance for process control
01/10/2008WO2008005338A1 Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
01/10/2008WO2008004673A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same
01/10/2008WO2008004416A1 Optically active 3-amino-2,5-dioxopyrrolidine-3-carboxylate, process for production of the compound, and use of the compound
01/10/2008WO2008004415A1 3-hydrazino-2,5-dioxopyrrolidine-3-carboxylate, process for production of the same, and use of the same
01/10/2008WO2008003871A1 New nitrones bearing a positive charge and suitable for use for the trapping of free radicals, and more particularly the peroxide radical
01/10/2008WO2008003697A1 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
01/10/2008WO2008003460A1 Process for the preparation of asenapine and intermediate products used in said process.
01/10/2008WO2007088571A3 A process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest
01/10/2008US20080009638 Process for the preparation of 2-oxo-1-pyrrolidine derivatives
01/10/2008US20080009637 Preparation of N-protected-3-pyrrolidine-lactam substituted phosphonium salts
01/10/2008US20080009630 Photogenerated reagents
01/10/2008US20080009621 Control of Cyanate in Aqueous Urea Solutions by non-1,2-Ethylene Diamine like Compounds for the Protection of Protein/Peptide Carbamylation
01/10/2008US20080009619 Process for the preparation of asenapine and intermediate products used in said process
01/10/2008US20080009541 N-{[2-chloro-3-(trifluoromethyl)phenyl]methyl}-1-methyl-5-oxoprolinamide; modulate P2X7 receptor function and are capable of antagonizing the effects of ATP at the P2X7 receptor; treatment of disorders mediated by the P2X7 receptor, for example pain, inflammation and neurodegeneration
01/10/2008US20080009522 Biphenylcarboxamides useful as lipid lowering agents
01/10/2008US20080009504 enzyme inhibitors of glucan synthase;1S,2R,3R,4aR,6aS,7R,8R,10aR,10bR,12aR)-3-(acetyloxy)-2-[(2S)-2-amino-2,3-dimethylbutyloxy]-8-[(1R)-1,2-dimethyl propyl]-1,6a,8,10a-tetramethyl-6-oxo-1,3,4,6,6a,7,8,9,10,10a,10b,11,12,12a-tetradecahydro-2H-1,4a-(methanooxymethano)chrysene-7-carboxylic acid
01/10/2008US20080009498 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use
01/10/2008US20080009489 Androgen receptor modulators and method of treating disease using the same
01/10/2008US20080008930 Ionic Liquid
01/10/2008US20080006797 Photochromic compound and optical functional material
01/10/2008CA2656921A1 3-hydrazino-2,5-dioxopyrrolidine-3-carboxylates and a process for preparing the same as well as a use of the same
01/10/2008CA2655675A1 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
01/10/2008CA2655670A1 Process for the preparation of asenapine and intermediate products used in said process
01/09/2008EP1875903A1 Tuberculosis treatment using pleuromutilin derivatives
01/09/2008EP1874771A2 Process for preparing bicyclic compounds
01/09/2008EP1874728A1 Composition of n-alkenyl carboxylic acid tertiary amide
01/09/2008EP1874727A1 New muscarinic receptor antagonists
01/09/2008EP1874723A2 New nitrogenated trans-stilbene analogs, method for the obtention and medical applications thereof
01/09/2008EP1874299A2 Vla-4 antagonists
01/09/2008EP1874298A2 Methods and compositions for production, formulation and use of 1-aryl-3-azabicyclo[3,1,0]hexanes
01/09/2008EP1751100B1 Anti-tubulin acting arylpyrrol, arylfulran and arylthiopene derivatives, method for the preparation and use thereof as an antimitotic
01/09/2008EP1638934B1 3-aminopyrrolidines as inhibitors of monoamine uptake
01/09/2008EP1490053B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
01/09/2008EP1263730B1 Amine derivatives for the treatment of apoptosis
01/09/2008EP1203047B1 Electrically conductive polymers capable of being covalently grafted on by light, method for obtaining same and uses as supports in probes for specific identification in electronic biosensors
01/09/2008EP1176956B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
01/09/2008CN101103015A 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver X receptor modulators
01/09/2008CN101102993A New one-step synthesis of useful disubstituted amines
01/09/2008CN100360532C Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
01/09/2008CN100360504C Sulfur-containing, polymerizable benzophenone photoinitiator and preparation method thereof
01/09/2008CN100360503C Process for rectifying N-vinyl-2-pyrrolidone
01/08/2008USRE40000 Method of treatment for decreasing mortality resulting from congestive heart failure
01/08/2008US7317123 Process for preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation
01/08/2008US7317111 derivatives of hydroxy-pyrene trisulphonic and disulphonic acids
01/08/2008US7317108 Acylating 1-monoacyldipyrromethane with an acid halide acylating agent in the presence of a Grignard reagent, to produce 1,9-diacyldipyrromethane metal complex;chemical intermediates; porphyrins
01/08/2008US7317102 Diarylmethyl and related compounds
01/08/2008US7317028 Antitumor agents; autoimmune disease; skin disorders; anticancer agents
01/08/2008US7317019 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity
01/08/2008US7317008 Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
01/08/2008CA2414311C Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
01/08/2008CA2228060C Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
01/08/2008CA2225830C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
01/03/2008WO2008002974A1 Pyrrole derivatives and their methods of use
01/03/2008WO2008002820A2 Substituted benzyl amine compounds
01/03/2008WO2008002655A2 Crystalline forms of atorvastatin
01/03/2008WO2008001752A1 Treatment of chronic obstructive pulmonary disease by statin
01/03/2008WO2008001718A1 Dehydroxylated fluorinating agent
01/03/2008WO2008001195A2 Novel processes for the preparation of dpp iv inhibitors
01/03/2008WO2008000951A2 Urea derivatives of tropane, their preparation and their therapeutic application
01/03/2008WO2008000651A1 Novel enzymatic process for boc-dap-oh
01/03/2008WO2008000131A1 α-AMINO-N-SUBSTITUTED AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF
01/03/2008WO2007127726A3 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
01/03/2008US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
01/03/2008US20080004330 Aminomethyl-Azacycle Derivatives as Inhibitors of Monoamine Uptake
01/03/2008US20080004321 Potentiators of Glutamate Receptors
01/03/2008US20080004315 Guanidine Derivatives and Therapeutic Uses Thereof
01/03/2008US20080004314 Phenylpiperidines and Phenylpyrrolidines
01/03/2008US20080004256 Amidinophenylalanine Derivatives as Thrombin Inhibitors
01/03/2008CA2656089A1 Substituted benzyl amine compounds
01/03/2008CA2655881A1 Crystalline forms of atorvastatin
01/03/2008CA2647601A1 Pyrrole derivatives and their methods of use
01/02/2008EP1871749A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
01/02/2008EP1871742A1 Preparation of ý2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)¨pyrrole derivatives
01/02/2008EP1871739A1 Compounds which inhibit beta-secretase activity and methods of use thereof
01/02/2008EP1644334B1 Antithrombotic ethers
01/02/2008EP1406859B1 Substituted 4-aminocyclohexanol derivatives
01/02/2008EP1210082B1 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions
01/02/2008CN101096356A Purification technique of 9-fluorenylmethoxycarbon succinimide ester
01/02/2008CN101095675A Dipeptidyl peptidase IV effectors
01/02/2008CN100358883C Five-membered aromatic heterocyclic compounds contg. beta-position trifluoromethyl group and synthesis thereof
01/02/2008CN100358867C Heterocyclic inhibitors of glycogen synthase kinase GSK-3
01/02/2008CN100358866C Method for preparing instable substituent N-containing pair of alkali-ethylene substitution pyrrole
01/01/2008US7314941 Synthesis of phosphono-substituted porphyrin compounds for attachment to metal oxide surfaces
01/01/2008US7314937 Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses
01/01/2008US7314932 Methods for minimizing thioamide impurities
01/01/2008US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1
01/01/2008US7314885 (4-(4-(2,3-difluorophenyl)-4H-1,2,4-triazol-3-yl)-1H-pyrrol-2-yl)(2H-pyrrol-1(5H)-yl)methanone; anticarcinogenic, antiproliferative and antimetastasis agent; inhibitors of c-Met protein kinase
01/01/2008US7314884 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile
01/01/2008US7314875 Tricyclic aromatic and bis-phenyl sulfinyl derivatives